Cargando…
The Nitric Oxide (NO) Donor Molsidomine Attenuates Memory Impairments Induced by the D1/D2 Dopaminergic Receptor Agonist Apomorphine in the Rat
Several lines of evidence suggest that scarcity of the gaseous molecule nitric oxide (NO) is associated with the pathogenesis of schizophrenia. Therefore, compounds, such as NO donors, that can normalize NO levels might be of utility for the treatment of this pathology. It has been previously shown...
Autores principales: | Vartzoka, Foteini, Ozenoglu, Elif, Pitsikas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574075/ https://www.ncbi.nlm.nih.gov/pubmed/37836704 http://dx.doi.org/10.3390/molecules28196861 |
Ejemplares similares
-
The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat
por: Katsanou, Lamprini, et al.
Publicado: (2023) -
Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors
por: Tirone, Mario, et al.
Publicado: (2016) -
Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats
por: Minaz, Nathani, et al.
Publicado: (2016) -
The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
por: Zoupa, Elli, et al.
Publicado: (2021) -
Examination of Imprinting Process with Molsidomine as a Template
por: Luliński, Piotr, et al.
Publicado: (2009)